We serve 1-propyl-3-methyl imidazolium hexafluorophosphate CAS:216300-12-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
nglish Name： 1-propyl-3-methyl imidazolium hexafluorophosphate
Synonyms:
1-Propyl-3-methylimidazolium hexafluorophosphate;1H-Imidazolium
1-methyl-3-propyl-, hexafluorophosphate(1-) (9CI)
1-Methyl-3-propyl-1H-imidazolium hexafluorophosphate;1H-Imidazolium
1-methyl-3-propyl-, hexafluorophosphate(1-) (1:1)
Molecular Formula： C7H13N2PF6
Molecular Weight： 270.16
CAS No.： 216300-12-8
Purity： 99%
Technical Information
| Appearance: | Purity: |
| NMR: Passed | null |
| Solubility: | Insolubility: |
|
Impurity content: (1) Methylimidazole content: < 1000 ppm; (2) Halogen content: < 1000 ppm; (3) Water content: < 1000 ppm |
|
Physics-Chemistry Properties
| Melting point: 40℃ | Decomposition temperature: 335℃ |
| Conductivity: | Electrochemical window: |
| Viscosity: 371cp | Density: |
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts
Contact us for information like 1-propyl-3-methyl imidazolium hexafluorophosphate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-methyl-3-propyl-, hexafluorophosphate(1-) (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-methyl-3-propyl-, hexafluorophosphate(1-) (9CI) Use and application,1-methyl-3-propyl-, hexafluorophosphate(1-) (1:1) technical grade,usp/ep/jp grade.
Related News: Any drug or medication is composed of two components.(S)-4-Benzyl-2-Oxazolidinone manufacturer Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.1-benzothiophene supplier Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.2-Amino-6-chloro-4-nitrophenol vendor The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.
